| Abigail M Burcham, SLP | |
|
2600 Greenbush St, Lafayette, IN 47904-2477 | |
| (765) 448-8000 | |
| Not Available |
| Full Name | Abigail M Burcham |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2600 Greenbush St, Lafayette, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386951473 | NPI | - | NPPES |
| 000000720648 | Other | IN | ANTHEM PROVIDER NUMBER |
| 201036550 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 46002137A (Indiana) | Secondary |
| 235Z00000X | Speech-language Pathologist | 22005353A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abigail M Burcham, SLP Po Box 5545, Lafayette, IN 47903-5545 Ph: (765) 448-8000 | Abigail M Burcham, SLP 2600 Greenbush St, Lafayette, IN 47904-2477 Ph: (765) 448-8000 |
News Archive
The first comprehensive study of its kind finds weight cycling, repeated cycles of intentional weight loss followed by regain, was not associated with overall risk of cancer in men or women. The study by American Cancer Society investigators is the largest to date to investigate weight cycling with cancer risk.
A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics
Patients hospitalized with COVID-19 were more likely male, younger, and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published by the Observational Health Data Sciences and Informatics community.
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems.
The U.S. Food and Drugs Administration (FDA) has restricted the use of the controversial diabetes drug Avandia (rosiglitazone) due to its propensity to increase cardiovascular disease risk.
› Verified 9 days ago
Hailey C Small, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 | |
Lauren Colbert, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr, Lafayette, IN 47905 Phone: 765-446-8300 Fax: 765-446-8301 | |
Ms. Gretchen Kay Foster, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Windy Hill Dr, Lafayette, IN 47905 Phone: 765-477-7791 Fax: 765-474-2986 | |
Heather Lavoine, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2303 Flowering Crab Dr W, Lafayette, IN 47905 Phone: 812-223-2250 | |
Alana Cowan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr Ste 5, Lafayette, IN 47905 Phone: 765-446-8300 | |
Monica Snyder, MS Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7625 | |
Taylor Weaver-rosamilia, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3700 Rome Dr, Lafayette, IN 47905 Phone: 765-448-4220 |